Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiye Yang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gynecologic Oncology|January 29, 2023
Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: A retrospective cohort studyYubo Zhang, Ruiye Yang, Chunyu Xu, et al.
Molecular Pharmaceutics|January 17, 2024
Immunotherapy for Ovarian Cancer: Disappointing or Promising?Mengqi Deng, Fan Tang, Xiangyu Chang, et al.
Pathology, Research and Practice|June 24, 2022
Analysis of the immune checkpoint lymphocyte activation gene-3 (LAG-3) in endometrial cancer: An emerging target for immunotherapyYubo Zhang, Ruiye Yang, Chunyu Xu, et al.
Ebiomedicine|October 8, 2025
B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer modelsQun Liu, Mengqi Deng, Junyi Jiang, et al.
Heliyon|November 25, 2024
HPV self-sampling for cervical cancer screening in China: A multi-center studyXuechao Ji, Menglin Hao, Yixiao Wang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gynecologic Oncology|January 29, 2023
Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: A retrospective cohort studyYubo Zhang, Ruiye Yang, Chunyu Xu, et al.
Molecular Pharmaceutics|January 17, 2024
Immunotherapy for Ovarian Cancer: Disappointing or Promising?Mengqi Deng, Fan Tang, Xiangyu Chang, et al.
Pathology, Research and Practice|June 24, 2022
Analysis of the immune checkpoint lymphocyte activation gene-3 (LAG-3) in endometrial cancer: An emerging target for immunotherapyYubo Zhang, Ruiye Yang, Chunyu Xu, et al.
Ebiomedicine|October 8, 2025
B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer modelsQun Liu, Mengqi Deng, Junyi Jiang, et al.
Heliyon|November 25, 2024
HPV self-sampling for cervical cancer screening in China: A multi-center studyXuechao Ji, Menglin Hao, Yixiao Wang, et al.
Pageof 2